Imaging the Vesicular Acetylcholine Transporter Using 18F-FEOBV PET in Parkinsons Disease
Trial
N/A
Completed
Jan. 30, 2023
Effects of Kinesthetic Stimuli During XBOX Kinect Training on People With Parkinson's Disease
Trial
N/A
Completed
Jan. 30, 2023
Fecal Microbiota Transplantation for Parkinson's Disease
Trial
N/A
Completed
Jan. 29, 2023
Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects
Trial
Phase 1
Completed
Jan. 25, 2023
Open Label Study for the Use of Transcranial Ultrasound Treatment of Tremor
Trial
Early Phase 1
Unknown
Jan. 25, 2023
Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson
Trial
Phase 1
Completed
Jan. 25, 2023
Non-Invasive Brain Stimulation for the Treatment of Parkinson´s Disease-related Pain
Trial
N/A
Completed
Jan. 25, 2023
Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Trial
N/A
Completed
Jan. 24, 2023
Role of Saffron and Chamomile in the Management of Parkinson's Disease
Trial
N/A
Unknown
Jan. 24, 2023
taVNS in Mild to Moderate Parkinson's Disease
Trial
N/A
Completed
Jan. 24, 2023
Asymmetric Targeted DBS for PD With PIGD
Trial
N/A
Unknown
Jan. 22, 2023
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
Trial
Phase 3
Terminated
Jan. 19, 2023
A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease
Trial
N/A
Terminated
Jan. 17, 2023
Gondola Mechanism of Action
Trial
N/A
Withdrawn
Jan. 17, 2023
Parkinson's Disease G2019S LRRK2 Genetic Testing Program
Trial
N/A
Terminated
Jan. 17, 2023
Monitoring Movement Disorder Symptoms With a Mobile Medical App on Off-the-shelf Consumer Mobile Devices
Trial
N/A
Unknown
Jan. 10, 2023
Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers
Trial
Phase 1
Completed
Jan. 10, 2023
Study of Motor Control Mechanisms in DBS-implanted Parkinson's Disease Patients
Trial
N/A
Terminated
Jan. 9, 2023
Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
Trial
Phase 1
Completed
Jan. 9, 2023